Verition Fund Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Verition Fund Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-153,354	Closed	-$10.7M	–	3609
2024 Q3	$10.7M	Buy	+153,354	New	+$10.5M	0.05%	377
2024 Q2	–	Sell	-147,364	Closed	-$10.2M	–	3341
2024 Q1	$10.2M	Buy	+147,364	New	+$9.94M	0.07%	332
2023 Q4	–	Sell	-5,663	Closed	-$318K	–	2746
2023 Q3	$318K	Buy	+5,663	New	+$319K	﹤0.01%	1696
2021 Q3	–	Sell	-3,759	Closed	-$238K	–	2381
2021 Q2	$238K	Buy	+3,759	New	+$222K	﹤0.01%	1474

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's AXNX Position: Q4 2024 in Review

Verition Fund Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 153,354 shares — an estimated $10.7M sold.

Verition Fund Management first reported a position in AXNX in Q2 2021 and held it in 4 quarters. The position peaked at $10.7M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Verition Fund Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Verition Fund Management sold 153,354 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $10.7M.
Verition Fund Management first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Verition Fund Management's Axonics, Inc. Common Stock position peaked at $10.7M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.